Press Releases

BOCA RATON, Fla. , March 09, 2022 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that...

BOCA RATON, Fla, March 09, 2022 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that its...

Sale permits Sensus to focus on the core dermatology market while providing capital for channel expansion BOCA RATON, Fla., March 02, 2022 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive,...

4Q21 diluted EPS of $0.32 on revenues of $13.0 million up 433% and 156%, respectively Affirms expectations for 1Q22 continued growth and full-year 2022 profitability Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 10, 2022 -- Sensus...

Michael J. Sardano named President, Christopher Machuzak and Jeffrey Starling named Regional Vice Presidents of SalesBOCA RATON, Fla, Jan. 31, 2022 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive...